LearnGlossaryMarketStocksSuperinvestorsSign in

OSUR

OraSure Technologies, Inc.

Healthcare · $231M market cap

Verdict

We can't put a fair value on OSUR right now. The financial data we receive for it contains an obvious error (its cash-flow profit is more than 10× its reported profit for the same year). We'll value it once the data is corrected.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth14.8% a year✓
Equity per share growth5.3% a year✗
Sales growth8.1% a year✗
Free cash flow growth32.9% a year✓
Return on invested capital-3.9%✗

Follow OSUR

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds OSUR. In Q2 2026, 1 opened a position. Who we track

First Eagle Investment Management

First Eagle Investment Management · as of Q2 2026

$4.7M

1,062,750 shares

Moves in Q2 2026

New position: First Eagle Investment Management

Insider activity

Since Sep 6, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Kenny John P.

director · 2026-09-06

Tax withholding

$18K

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works